Optimising Real World Data Use to Drive Effective Outcomes
Real world evidence (RWE) continues to drive healthcare and research discussions and decisions. ICON works with biopharmaceutical and medical device companies to identify, generate, and communicate the clinical, safety and cost-effectiveness evidence that regulators, payers and providers demand.
A Strategic Approach to RWE Generation
Our experts collaborate with your subject matter experts to deliver a unique, intelligent RWE strategy for increased clinical research efficiency, and targeted plans that can enhance your value story and provide compelling evidence for stakeholder engagement. We call this approach Real World Intelligence™.
From interactive evidence planning workshops and strategy creation to implementation of innovative technology and RWD solutions, we ensure that you are on the clear path to commercial success, equipped with the right RWD assets to generate impactful evidence.
RWE Planning Workshops and Strategy Creation
Our interactive workshop approach brings together subject matter and functional experts to create a roadmap that aligns with your strategic objectives. You get a step-by-step plan to identify and execute a comprehensive RWE strategy customised for your specific asset.
RWE Technology Solutions
The evidence generated from collecting, standardising and analysing RWD from primary and secondary sources can be used across an array of late phase research applications. With a full understanding of the novel RWD sources and innovative technologies to gather, process and analyse them, a more robust approach exists for creating RWE results.
At ICON, we take a novel approach to RWE Technology by leveraging:
- RWD sources
- Technology enablement
- Future investments
Greater use of secondary RWD
- Innovative study designs
- Patient recruitment
EHR research platforms
- Hybrid studies
- Backbone for data collection
- Pragmatic trials
- ePRO, retention and recruitment
- Virtual studies
RWE Technology Platform
ICON provides a configurable technology platform, that leverage Saama’s Life Science Analytics Cloud, and is a fit-for-purpose solution to support and enhance observational research and gather disparate RWD assets into a common data model, provide analytics to support multiple audiences across the product lifecycle, and establish a central repository and analytic platform for all of your RWD assets.